Skip to main content
. Author manuscript; available in PMC: 2013 May 29.
Published in final edited form as: Immunotherapy. 2011 Jul;3(7):853–870. doi: 10.2217/imt.11.61

Table 1.

Maintenance immunosuppressive therapies in transplantation and autoimmune disease.

Drugs Mechanisms Side effects
Azathioprine Inhibits purine and DNA synthesis, inhibits cell proliferation Bone marrow depression, opportunistic infection, macrocytosis and liver toxicity

Cyclosporine Binds to cyclophilin, inhibits calcineurin phosphatase, blocks NF-AT dephosphorylation, blocks IL-2 transcription and T-cell activation Hypertension, hyperlipidemia, nephrotoxicity, hepatotoxicity, pancreatitis, peptic ulcers, thrombotic microangiopathy, opportunistic infection, neurotoxicity, tremor, gingival hyperplasia and hirsutism

Methotrexate Irreversibly inhibits DHFR, blocks folic acid synthesis, interferes with synthesis of DNA, RNA, thimidylates and proteins Pulmonary fibrosis, hepatitis, anemia, neutropenia, hair loss, gastrointestinal symptoms and dermatitis

Mycophenolate mofetil Inhibits inosine-monophosphate dehydrogenase, inhibits purine synthesis and blocks cell proliferation Gastrointestinal symptoms, bone marrow depression, opportunistic infection in particular CMV and BK nephropathy

Sirolimus Binds to FKBP12, inhibits mTOR and blocks IL-2-driven cell proliferation Delayed graft function, delayed wound healing, mouth ulcers, pneumonitis, increased proteinuria, peripheral edema and hyperlipidemia

Steroids Induces phospholipase A2 inhibitory proteins, inhibits arachidonic acid synthesis, inhibits prostaglandins and leukotrienes Diabetes, delayed wound healing, peptic ulcers, psychosis, osteoporosis, infection, blurred vision, fluid retention, weight gain, acne and constipation

Tacrolimus Binds to FKBP12, inhibits calcineurin phosphatase and blocks T-cell activation Post-transplantation diabetes mellitus, nephrotoxicity, thrombotic microangiopathy and neurotoxicity

Fingolimod (FTY720) Modulation of the spingosine-1-phosphate receptors Adverse events reported in up to 10.7% of patients. All related to mechanism of action and include cardiovascular and infections. Isolated cases of ischemic stroke, vascular occlusion and encephalopathy have been reported [119,131]

CMV: Cytomegalovirus; DHFR: Dihydrofolate reductase; NF-AT: Nuclear factor of activated T cell.